NCT02978482 2021-08-18
A Phase 1/2 Study of Durvalumab(MEDI4736) and Tremelimumab in Chinese Patients With Advanced Malignancies
AstraZeneca
Phase 1 Completed
Clinical Trials
3 trialsNCT04216082 2020-01-02
A Study of Anlotinib in Subjects With Advanced Malignancy
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Phase 2 Completed
NCT00978926 2010-04-09
A Study of the Pharmacodynamic Effects of Anti-Vascular Endothelial Growth Factor Therapy in Patients With Advanced Malignancies
National University Hospital, Singapore
Completed